道琼斯指数
52,333.04
涨跌
-28.54-0.05%
在 MEXC 探索美国生物科技板块股票,涵盖专注于药物研发、基因治疗及生物学研究的公司。比较股价、当日涨跌、市值和成交量,全面了解生物科技行业动态。

今日美股市场走势分化,道琼斯指数涨跌幅为 -0.05%,标普 500 指数为 +0.53%,纳斯达克综合指数为 +1.16%。个股方面,2,394 只上涨、2,723 只下跌,市场整体呈现分化格局。
| # | 股票 | 52 周价格区间 | |||||
|---|---|---|---|---|---|---|---|
| 1 | Amgen Inc.AMGN | $448.11 | +0.63% | 661.17K | $242.26B | $288.00 - $450.98 | 0.02% |
| 2 | Gilead Sciences Inc.GILD | $158.10 | -0.51% | 2.05M | $196.04B | $114.02 - $160.51 | 0.02% |
| 3 | Moderna, Inc.MRNA | $197.68 | -0.55% | 11.21M | $78.92B | $22.28 - $254.48 | 0.00% |
| 4 | IQVIA Holdings Inc.IQV | $270.76 | -1.07% | 1.18M | $44.57B | $154.50 - $289.73 | 0.00% |
| 5 | Revolution Medicines, Inc.RVMD | $186.41 | +1.21% | 576.66K | $39.95B | $55.40 - $224.31 | 0.00% |
| 6 | Biogen Inc.BIIB | $251.69 | -0.31% | 335.74K | $37.19B | $138.00 - $254.41 | 0.00% |
| 7 | Incyte Genomics Inc.INCY | $115.77 | +2.40% | 701.71K | $23.47B | $84.02 - $132.60 | 0.00% |
| 8 | Medpace Holdings, Inc.MEDP | $676.98 | +0.01% | 87.61K | $18.94B | $373.00 - $684.52 | 0.00% |
| 9 | Charles River Laboratories International, Inc.CRL | $356.39 | -0.07% | 350.77K | $17.01B | $146.19 - $360.40 | 0.00% |
| 10 | Exelixis Inc.EXEL | $65.31 | -0.10% | 490.68K | $16.18B | $36.00 - $65.58 | 0.00% |
| 11 | Neurocrine Biosciences Inc.NBIX | $144.72 | -0.48% | 443.68K | $14.71B | $122.14 - $186.12 | 0.00% |
| 12 | Halozyme Therapeutics, Inc.HALO | $128.52 | +0.23% | 534.20K | $14.59B | $61.23 - $128.87 | 0.00% |
| 13 | Bio-Techne Corp.TECH | $72.67 | -0.01% | 1.41M | $11.40B | $43.20 - $72.75 | 0.00% |
| 14 | Twist Bioscience CorporationTWST | $158.36 | +8.56% | 907.99K | $9.93B | $23.30 - $219.71 | 0.00% |
| 15 | Kymera Therapeutics, Inc.KYMR | $118.37 | +2.95% | 315.70K | $9.84B | $55.66 - $130.05 | 0.00% |
| 16 | Repligen Corp.RGEN | $174.37 | -3.44% | 962.75K | $9.84B | $100.99 - $198.87 | 0.00% |
| 17 | Krystal Biotech, Inc.KRYS | $315.66 | +0.61% | 64.93K | $9.34B | $183.26 - $382.54 | 0.00% |
| 18 | ImmunityBio, Inc.IBRX | $8.54 | +9.15% | 6.19M | $9.05B | $1.95 - $12.43 | 0.00% |
| 19 | Vaxcyte, Inc.PCVX | $60.15 | +0.37% | 738.78K | $8.95B | $39.87 - $90.75 | 0.00% |
| 20 | Iovance Biotherapeutics, Inc.IOVA | $14.55 | +5.66% | 5.41M | $6.59B | $1.76 - $15.37 | 0.00% |
| 21 | Immunovant, Inc.IMVT | $28.58 | +1.46% | 269.56K | $5.90B | $19.21 - $45.42 | 0.00% |
| 22 | CG Oncology, Inc.CGON | $63.88 | +3.40% | 160.21K | $5.66B | $35.80 - $80.97 | 0.00% |
| 23 | Kodiak Sciences Inc.KOD | $90.08 | +1.18% | 449.27K | $5.66B | $15.83 - $104.00 | 0.00% |
| 24 | Scholar Rock Holding CorporationSRRK | $42.51 | +1.61% | 288.98K | $5.18B | $27.07 - $61.76 | 0.00% |
| 25 | CRISPR Therapeutics AGCRSP | $50.80 | +3.69% | 443.55K | $4.91B | $44.12 - $67.73 | 0.00% |
| 26 | Adaptive Biotechnologies CorporationADPT | $27.59 | +4.57% | 514.11K | $4.40B | $12.00 - $30.74 | 0.00% |
| 27 | Relay Therapeutics, Inc.RLAY | $18.64 | +2.73% | 949.42K | $4.08B | $5.95 - $21.27 | 0.00% |
| 28 | Tarsus Pharmaceuticals, Inc.TARS | $70.89 | +1.40% | 123.27K | $3.50B | $53.89 - $91.53 | 0.00% |
| 29 | Denali Therapeutics Inc.DNLI | $19.05 | +2.22% | 546.00K | $3.05B | $13.75 - $27.30 | 0.00% |
| 30 | Beam Therapeutics Inc.BEAM | $24.79 | +4.08% | 804.53K | $2.56B | $20.23 - $38.26 | 0.00% |
| 31 | ADMA Biologics, Inc.ADMA | $11.04 | -0.05% | 644.08K | $2.47B | $7.21 - $20.46 | 0.00% |
| 32 | Vericel CorporationVCEL | $43.48 | +1.07% | 146.07K | $2.23B | $28.95 - $49.32 | 0.00% |
| 33 | Recursion Pharmaceuticals, Inc.RXRX | $4.08 | +6.84% | 12.45M | $2.19B | $2.77 - $6.50 | 0.00% |
| 34 | BioCryst Pharmaceuticals Inc.BCRX | $7.99 | +1.59% | 3.73M | $2.04B | $6.23 - $11.22 | 0.00% |
| 35 | Vir Biotechnology, Inc.VIR | $11.09 | +0.50% | 564.86K | $1.88B | $4.82 - $12.00 | 0.00% |
| 36 | Absci CorporationABSI | $10.43 | +11.11% | 2.76M | $1.79B | $2.24 - $12.05 | 0.00% |
| 37 | Maze Therapeutics, Inc.MAZE | $31.30 | +1.06% | 124.42K | $1.72B | $21.95 - $53.65 | 0.00% |
| 38 | Hemab Therapeutics Holdings, Inc.COAG | $37.38 | +3.39% | 120.09K | $1.61B | $23.00 - $55.42 | 0.00% |
| 39 | Novavax Inc.NVAX | $9.73 | +3.40% | 3.21M | $1.61B | $6.20 - $13.38 | 0.00% |
| 40 | Inhibrx Biosciences, Inc.INBX | $96.33 | +9.51% | 140.08K | $1.42B | $53.39 - $155.29 | 0.00% |
| 41 | Taysha Gene Therapies, Inc.TSHA | $4.11 | +2.49% | 1.17M | $1.34B | $3.46 - $7.30 | 0.00% |
| 42 | Replimune Group, Inc.REPL | $12.93 | +3.37% | 1.43M | $1.21B | $1.50 - $16.33 | 0.00% |
| 43 | Vor Biopharma Inc.VOR | $18.46 | +0.57% | 277.36K | $1.09B | $6.50 - $28.66 | 0.00% |
| 44 | Cullinan Therapeutics, Inc.CGEM | $14.74 | +1.38% | 138.54K | $948.59M | $6.73 - $23.19 | 0.00% |
| 45 | Odyssey Therapeutics, Inc.ODTX | $19.14 | -1.04% | 69.38K | $941.95M | $15.10 - $29.05 | 0.00% |
| 46 | MeiraGTx Holdings plcMGTX | $9.42 | +2.83% | 219.98K | $904.82M | $6.62 - $15.35 | 0.00% |
| 47 | Monte Rosa Therapeutics, Inc.GLUE | $10.54 | +0.67% | 620.39K | $898.78M | $9.68 - $25.77 | 0.00% |
| 48 | Prime Medicine, Inc.PRME | $4.08 | +13.16% | 4.37M | $739.11M | $2.67 - $5.20 | 0.00% |
| 49 | Sana Biotechnology, Inc.SANA | $2.44 | +2.75% | 858.97K | $728.94M | $2.22 - $5.70 | 0.00% |
| 50 | OmniAb, Inc.OABI | $4.91 | +6.40% | 378.79K | $711.09M | $1.30 - $5.43 | 0.00% |
| 现货美股(RealStocks) | 代币化美股(Tokenized Stocks) | 股票合约(Stock Futures) | |
|---|---|---|---|
| 是什么 | 美股上市公司的真实股份(现货美股) | 与美股/ETF 挂钩的区块链代币 | 以 USDT 保证金进行的股价合约交易 |
| 所有权 | 是 —— 真实持股 | 否 —— 仅为合成敞口 | 否 —— 仅为衍生品敞口 |
| 股东权益 | 有(如分红) | 无 | 无 |
| 交易时间 | 美股交易时段(盘前、正常、盘后、隔夜) | 24/7 全天候 | 支持交易对最高可达 24/7 全天候 |
| 持仓方式 | 买入并持有 | 买入并持有 | 支持多空双向、杠杆交易 |
| 适合人群 | 追求长期持有和分红收益的投资者 | 希望全天候获得股票敞口、无需持有股票的交易者 | 希望通过杠杆进行投机或对冲的短线/活跃交易者 |
通过 MEXC 合作的持牌券商购买真实美股,并可按适用条件享有股息等股东权益。
覆盖 7,000+ 只美国上市股票及 ETF,涵盖科技、金融、医疗、消费等多个行业。
支持 USDT 转入及 USDT/USD 转换,更便捷地为 RealStocks 账户提供资金。
以具有竞争力的交易成本参与真实美股交易,让更多资金用于投资策略。
本页面展示的美股价格、指数、排行榜、图表及其他市场数据可能来自第三方数据提供商,并可能存在延迟或误差。MEXC 提供的相关信息仅供参考和教育用途,不对其准确性或完整性作出保证。页面内容不构成任何金融或投资建议,也不构成买卖任何证券的推荐。美股交易存在风险,历史表现不代表未来结果,用户应在作出投资决定前进行独立研究。